TCTR20200313005Enrolling By Invitation未知
Effectiveness and safety of direct acting antivirals for the management of patients with chronic hepatitis C virus in Thailand : A real-life multicenter study.
适应症
试验速览
- 阶段
- 未知
- 状态
- Enrolling By Invitation
- 发起方
- one
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 70 Years（—）
- 性别
- All
入选标准
- •1. Patients aged 18 years and older who are admitted to institutions participating in the chronic hepatitis C research project during the year 2015-present
- •2. Patients are treated with Direct Acting Antivirals and may or may not be combined with ribavirin.
排除标准
- •1. Patients younger than 18 years of age
- •2. Pregnant patients.
研究者
相似试验
已完成
不适用
Assessment of indication and efficacy of anti-viral therapy based on mucosal PCR assay in active UC patients with CMV infection.lcerative colitisJPRN-UMIN000022588Department of Gastroenterology and Hepatology, Kyoto University Hospital120
已完成
不适用
Analysis of efficacy and safety of antiviral therapy with daclatasvir and asunaprevir for recurrent hepatitis C after liver transplantatiohepatitis C after liver transplantationJPRN-UMIN000014583Kyoto University Hospital30
已完成
不适用
Analysis of efficacy and safety of antiviral therapy with daclatasvir and asunaprevir for hepatitis C after organ transplantation -Pilot Studyhepatitis C after transplantationJPRN-UMIN000016558Trasnplantation surgery, Hiroshima University Hospital20
招募中
不适用
Analysis of efficacy and safety of antiviral therapy with telaprevir, peginterferon and ribavirin for recurrent hepatitis C after liver transplantatiohepatitis C after liver transplantationJPRN-UMIN000009171Kyoto University Hospital20
招募中
不适用
Analysis of efficacy and safety of antiviral therapy with simeprevir, peginterferon and ribavirin for recurrent hepatitis C after liver transplantatiohepatitis C after liver transplantationJPRN-UMIN000012219Kyoto University Hospital30